Breast Cancer Res. Treat. 2020 Feb 01
Anastrozole plus fulvestrant vs. anastrozole alone for hormone receptor-positive advanced breast cancer: a meta-analysis of randomized controlled trials.
Li M, Xiong Y, Liao C, He Y, Duan S, Yi F, Wei Y, Zhang W
For patients with hormone receptor (HR)-positive advanced breast cancer, whether the combination of anastrozole and fulvestrant is more effective than ...
Read More
Source: PubMed
Complement Ther Med
The effect of oral capsule of curcumin and vitamin E on the hot flashes and anxiety in postmenopausal women: A triple blind randomised controlled trial.
Ataei-Almanghadim K, Farshbaf-Khalili A, Ostadrahimi AR, Shaseb E, Mirghafourvand M
The decline and eventual cessation of estrogen production cause a variety of symptoms during menopause, affecting each woman differently. Most women r ...
Read More
Source: PubMed
Future Oncol 2020 Jan 27
Safety of antiemetic prophylaxis with HTX-019 as a 30-min infusion in patients with cancer: a retrospective study.
Perry TS, Dickson N, Patton JF
Aim: The neurokinin 1 receptor antagonist HTX-019 (CINVANTI® [aprepitant injectable emulsion]) was approved for preventing chemotherapy-induced nausea ...
Read More
Source: PubMed
Breast Cancer Res. Treat. 2020 Feb 01
Anastrozole plus fulvestrant vs. anastrozole alone for hormone receptor-positive advanced breast cancer: a meta-analysis of randomized controlled trials.
Li M, Xiong Y, Liao C, He Y, Duan S, Yi F, Wei Y, Zhang W
For patients with hormone receptor (HR)-positive advanced breast cancer, whether the combination of anastrozole and fulvestrant is more effective than ...
Read More
Source: PubMed
Support Care Cancer 2020 Jan 24
Pain, fatigue and depression symptom cluster in survivors of prostate cancer.
Baden M, Lu L, Drummond FJ, Gavin A, Sharp L
Pain, fatigue and depression are common sequelae of a cancer diagnosis. The extent to which these occur together in prostate cancer survivors is unkno ...
Read More
Source: PubMed
Complement Ther Med
The effect of oral capsule of curcumin and vitamin E on the hot flashes and anxiety in postmenopausal women: A triple blind randomised controlled trial.
Ataei-Almanghadim K, Farshbaf-Khalili A, Ostadrahimi AR, Shaseb E, Mirghafourvand M
The decline and eventual cessation of estrogen production cause a variety of symptoms during menopause, affecting each woman differently. Most women r ...
Read More
Source: PubMed
Menopause 2020 Jan 20
Lights on MsFLASH: a review of contributions.
Reed SD, LaCroix AZ, Anderson GL, Ensrud KE, Caan B, Carpenter JS, Cohen L, Diem SJ, Freeman EW, Joffe H, Larson JC, McCurry SM, Mitchell CM, Newton KM, Sternfeld B, Guthrie KA
The Menopause Strategies: Finding Lasting Answers for Symptoms and Health clinical trials network was funded by the National Institutes of Health to f ...
Read More
Source: PubMed
Future Oncol 2020 Jan 27
Safety of antiemetic prophylaxis with HTX-019 as a 30-min infusion in patients with cancer: a retrospective study.
Perry TS, Dickson N, Patton JF
Aim: The neurokinin 1 receptor antagonist HTX-019 (CINVANTI® [aprepitant injectable emulsion]) was approved for preventing chemotherapy-induced nausea ...
Read More
Source: PubMed
Support Care Cancer 2020 Jan 24
Pain, fatigue and depression symptom cluster in survivors of prostate cancer.
Baden M, Lu L, Drummond FJ, Gavin A, Sharp L
Pain, fatigue and depression are common sequelae of a cancer diagnosis. The extent to which these occur together in prostate cancer survivors is unkno ...
Read More
Source: PubMed
Menopause 2020 Jan 20
Lights on MsFLASH: a review of contributions.
Reed SD, LaCroix AZ, Anderson GL, Ensrud KE, Caan B, Carpenter JS, Cohen L, Diem SJ, Freeman EW, Joffe H, Larson JC, McCurry SM, Mitchell CM, Newton KM, Sternfeld B, Guthrie KA
The Menopause Strategies: Finding Lasting Answers for Symptoms and Health clinical trials network was funded by the National Institutes of Health to f ...
Read More
Source: PubMed
Breast Cancer Res. Treat. 2020 Feb 01
Anastrozole plus fulvestrant vs. anastrozole alone for hormone receptor-positive advanced breast cancer: a meta-analysis of randomized controlled trials.
Li M, Xiong Y, Liao C, He Y, Duan S, Yi F, Wei Y, Zhang W
For patients with hormone receptor (HR)-positive advanced breast cancer, whether the combination of anastrozole and fulvestrant is more effective than ...
Read More
Source: PubMed
Complement Ther Med
The effect of oral capsule of curcumin and vitamin E on the hot flashes and anxiety in postmenopausal women: A triple blind randomised controlled trial.
Ataei-Almanghadim K, Farshbaf-Khalili A, Ostadrahimi AR, Shaseb E, Mirghafourvand M
The decline and eventual cessation of estrogen production cause a variety of symptoms during menopause, affecting each woman differently. Most women r ...
Read More
Source: PubMed
Future Oncol 2020 Jan 27
Safety of antiemetic prophylaxis with HTX-019 as a 30-min infusion in patients with cancer: a retrospective study.
Perry TS, Dickson N, Patton JF
Aim: The neurokinin 1 receptor antagonist HTX-019 (CINVANTI® [aprepitant injectable emulsion]) was approved for preventing chemotherapy-induced nausea ...
Read More
Source: PubMed
Support Care Cancer 2020 Jan 24
Pain, fatigue and depression symptom cluster in survivors of prostate cancer.
Baden M, Lu L, Drummond FJ, Gavin A, Sharp L
Pain, fatigue and depression are common sequelae of a cancer diagnosis. The extent to which these occur together in prostate cancer survivors is unkno ...
Read More
Source: PubMed
Menopause 2020 Jan 20
Lights on MsFLASH: a review of contributions.
Reed SD, LaCroix AZ, Anderson GL, Ensrud KE, Caan B, Carpenter JS, Cohen L, Diem SJ, Freeman EW, Joffe H, Larson JC, McCurry SM, Mitchell CM, Newton KM, Sternfeld B, Guthrie KA
The Menopause Strategies: Finding Lasting Answers for Symptoms and Health clinical trials network was funded by the National Institutes of Health to f ...
Read More
Source: PubMed
